Federal Register of Legislation - Australian Government

Primary content

PB 27 of 2011 Determinations/Health as made
This Determination amends the National Health (Listed drugs on F1 or F2) Determination 2010 (No. PB 93 of 2010) to place drugs into the F1 or F2 formulary for the PBS. It adds the listed drugs adapalene with benzoyl peroxide, romiplostim and zonisamide to F1 formulary, moves the listed drugs filgrastim, idarubicin, pioglitazone and risedronic acid from F1 to F2 formulary and also removes three drugs, dydrogesterone, sitaxentan and zuclopenthixol decanoate from F1 as they will no longer be listed on the PBS from 1 April 2011.
Administered by: Health
Registered 31 Mar 2011
Tabling HistoryDate
Tabled HR10-May-2011
Tabled Senate10-May-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.4)

Instrument number PB 27 of 2011

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                 28                March  2011

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

 

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.4).

         (2)   This Determination may also be cited as PB 27 of 2011.

2              Commencement

                This Determination commences on 1 April 2011.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Adalimumab

                  

Insert

 

          Adapalene with benzoyl peroxide

 

[2]     Schedule 1, after item dealing with Dutasteride

                  

Omit

 

           Dydrogesterone

 

[3]     Schedule 1, after item dealing with Ferrous sulphate

                  

Omit

 

                     Filgrastim

 

[4]     Schedule 1, after item dealing with Ibuprofen

                  

Omit

 

                    Idarubicin

 

[5]     Schedule 1, after item dealing with Pimecrolimus

                  

Omit

 

                    Pioglitazone

 

[6]     Schedule 1, after item dealing with Riluzole

                  

Omit

 

                    Risedronic acid

 

[7]     Schedule 1, after item dealing with Rizatriptan

                  

Insert

 

                    Romiplostim

 

[8]     Schedule 1, after item dealing with Sitagliptin

                  

Omit

 

                    Sitaxentan

 

[9]     Schedule 1, after item dealing with Zolmitriptan

                  

                   Omit

 

                    Zuclopenthixol decanoate

 

Insert

 

                    Zonisamide

 

[10]   Schedule 2, after item dealing with Felodipine

                  

Insert

 

          Filgrastim

 

[11]   Schedule 2, after item dealing with Hypromellose with dextran

                  

Insert

 

          Idarubicin

 

 

[12]   Schedule 2, after item dealing with Pindolol

                  

Insert

 

          Pioglitazone

 

[13]   Schedule 2, after item dealing with Ranitidine

                  

Insert

 

          Risedronic acid

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.